Chemcrux Enterprises Ltd

Chemcrux Q1 FY2025 Results: Revenue Holds Steady, Profits Dip 📉

- Standalone revenue for Q1 FY2025: ₹1,674.74L (vs. ₹1,710.85L in Q1 FY2024).

- Standalone PBT for Q1 FY2025: ₹73.06L (down from ₹176.11L YoY).

- Standalone PAT for Q1 FY2025: ₹58.45L (vs. ₹123.82L YoY).

- Standalone EPS for Q1 FY2025: ₹0.39 (down from ₹0.84 YoY).

- Consolidated revenue for Q1 FY2025: ₹1,650.35L (vs. ₹1,710.85L YoY).

- Consolidated PBT for Q1 FY2025: ₹3.09L (vs. ₹176.11L YoY).

- Consolidated PAT for Q1 FY2025: ₹9.27L (down from ₹123.82L YoY).

- Consolidated EPS for Q1 FY2025: ₹0.06 (vs. ₹0.84 YoY).

- Acquired remaining 50% stake in Kalichem Private Limited (now wholly-owned subsidiary).